Business Wire

Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys

PARIS--(BUSINESS WIRE)--Gradient Denervation Technologies (“Gradient”), a medical device company developing an innovative catheter-based solution for the treatment of pulmonary hypertension, announces ...
KOLR10 & Ozarks Local News

Gradient Denervation Technologies Enrolls Initial Patient in First-In-Human Study of Pulmonary Artery Denervation Technology

PARIS, FRANCE / ACCESSWIRE / June 1, 2023 / Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive device for treating certain heart failure patients ...
WCBD

Gradient Denervation Technologies Announces FDA Breakthrough Designation for Pulmonary Artery Denervation System

PARIS, May 19, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough Device Designation by the U.S. Food and ...
KTLA

Gradient Denervation Technologies Enrolls First Patient in Early Feasibility Study of Pulmonary Artery Denervation System

PARIS, March 6, 2024 /PRNewswire/ -- Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive, ultrasound-based device designed to treat pulmonary ...
BioWorld

Gradient raises €14M for catheter device to treat pulmonary hypertension

Gradient Denervation Technologies SAS closed a €14 million (US$15 million) series A financing round that will help the company with the ongoing clinical development and evaluation of its ...